Interactions between NTS2 neurotensin and opioid receptors on two nociceptive responses assessed on the hot plate test in mice

Behavioural Brain Research

Volumn 175, Issue 2, 2006, Pages 399-407

  Bredeloux, Pierre ^a   Costentin, Jean ^a   Dubuc, Isabelle ^a  

^a CNRS   (France)

Author keywords

Hot plate test; Mice; Morphine; NTS2 receptors; Opioid receptors; Peptide NT1

Indexed keywords

2 [[1 (7 CHLORO 4 QUINOLINYL) 5 (2,6 DIMETHOXYPHENYL) 3 PYRAZOLYL]CARBONYLAMINO] 2 ADAMANTANECARBOXYLIC ACID; HEXAPEPTIDE; LEVOCABASTINE; MORPHINE; NALOXONE; NEUROTENSIN 2 RECEPTOR; OPIATE RECEPTOR; RECEPTOR SUBUNIT; UNCLASSIFIED DRUG;

ANALGESIC ACTIVITY; ANIMAL BEHAVIOR; ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; HOT PLATE TEST; LICKING; MALE; MOUSE; NEUROPHARMACOLOGY; NEUROTRANSMISSION; NOCICEPTION; NONHUMAN; PHARMACOLOGICAL BLOCKING; PRIORITY JOURNAL; PROTEIN PROTEIN INTERACTION; RECEPTOR INTRINSIC ACTIVITY;

ANALGESIA; ANALGESICS, OPIOID; ANIMALS; DOSE-RESPONSE RELATIONSHIP, DRUG; HISTAMINE H1 ANTAGONISTS, NON-SEDATING; INJECTIONS, INTRAVENTRICULAR; LIGANDS; MALE; MICE; MORPHINE; NEUROTENSIN; PAIN THRESHOLD; PIPERIDINES; PYRAZOLES; QUINOLINES; REACTION TIME; RECEPTORS, NEUROTENSIN; RECEPTORS, OPIOID;

EID: 33750982434     PISSN: 01664328     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bbr.2006.09.016     Document Type: Article

References (30)

1. Akil H., Owens C., Gutstein H., Taylor L., Curran E., and Watson S. Endogenous opioids: overview and current issues. Drug Alcohol Depend 51 (1998) 127-140
2. Asselin M.L., Dubuc I., Coquerel A., and Costentin J. Localization of neurotensin nts2 receptors in rat brain. Neuroreport 12 (2001) 1087-1091
3. Buhler A.V., Choi J., Proudfit H.K., and Gebhart G.F. Neurotensin activation of the NTS1 on spinally-projecting serotoninergic neurons in the rostral ventromedial medulla is antinociceptive. Pain 114 (2005) 285-294
4. Chalon P., Vita N., Kaghad M., Guillemot M., Bonnin J., Delpech B., et al. Molecular cloning of a levocabastine-sensitive neurotensin site. FEBS Lett 386 (1998) 91-94
5. Clineschmidt B.V., McGuffin J.C., and Bunting P.B. Neurotensin: antinocisponsive action in rodents. Eur J Pharmacol 54 (1979) 129-139
6. Coquerel A., Dubuc I., Kitabgi P., and Costentin J. Potentiation by thiorphan and bestatin of the naloxone-insensitive analgesic effects of neurotensin and neuromedin N. Neurochem Int 12 (1988) 361-366
7. Costentin J., Vlaiculescu A., Chaillet P., Ben Natan L., Aveaux D., and Schwartz J.C. Dissociated effects of inhibitors of metabolizing peptidases or naloxone on various nociceptive responses. Eur J Pharmacol 123 (1986) 37-44
8. Dubuc I., Remande S., and Costentin J. The partial agonist properties of levocabastine in neurotensin-induced analgesia. Eur J Pharmacol 381 (1999) 9-12
9. Dubuc I., Sarret P., Labbé-Jullié C., Botto J.M., Honoré E., Bourdel E., et al. Identification of the receptor subtype involved in the analgesic effect of neurotensin. J Neurosci 19 (1999) 503-510
10. Eddy W., and Leimbach D. Synthetic analgesic (II) Dithenylbutenyl and dithenylbutylamine. J Pharmacol Exp Ther 107 (1953) 385-393
11. Gully D., Canton M., Boigegrain R., Jeanjean F., Molimard J.C., Poncelet M., et al. Biochemical and pharmacological profile of a potent and selective nonpeptide antagonist of the neurotensine receptor. Proc Natl Acad Sci USA 90 (1993) 65-69
12. Kest B., Adler M., and Hopkins E. Sex differences in thermoregulation after acute and chronic morphine administration in mice. Neurosci Lett 291 (2000) 126-128
13. Langlois X., Te Riele P., Wintmolders C., Leysen J.E., and Jurzak M. Use of the beta-imager for rapid ex-vivo autoradiography exemplified with central nervous system penetrating neurokinin 3 antagonists. J Pharmacol Exp Ther 299 (2001) 712-717
14. Luttinger D., Burgess S.K., Nemeroff C.B., and Prange Jr. A.J. The effects of chronic morphine treatment on neurotensin-induced antinociception. Psychopharmacology (Berl) 81 (1983) 10-13
15. Maeno H., Yamada K., Santo-Yamada Y., Aoki K., Sun Y.J., Sato E., et al. Comparison of mice deficient in the high- or low-affinity neurotensin receptors, Ntsr1 or Ntsr2, reveals a novel function for Ntsr2 in thermal nociception. Brain Res 998 (2004) 122-129
16. Mazella J., Botto J.M., Guillemare E., Coppola T., Sarret P., and Vincent J.P. Structure, functional expression and cerebral localization of levocabastine-sensitive neurotensin/neuromedin N receptor from mouse brain. J Neurosci 16 (1996) 5613-5620
17. Mazella J., Zsürger N., Navarro V., Chabry J., Kaghad M., Caput D., et al. The 100 kDa neurotensin receptor is gp95/sortilin, a non-G-protein-coupled receptor. J Biol Chem 273 (1998) 26273-26276
18. Nemeroff C.B., Osbahr A.J., Manberg P.J., Ervin G.N., and Prange Jr. A.J. Alterations in nociception and body temperature after intracisternal administration of neurotensin, β-endorphin, other endogenous peptides, and morphine. Proc Natl Acad Sci USA 76 (1979) 5368-5371
19. Osbahr A.J., Nemeroff C.B., Luttinger D., Mason G.A., and Prange Jr. A.J. Neurotensin-induced antinociception in mice: antagonism by thyrotropin-releasing hormone. J Pharmacol Exp Ther 217 (1981) 645-651
20. Petersen C.M., Nielsen M.S., Nykjaer A., Jacobsen L., Tommerup N., Rasmussen H.H., et al. Molecular identification of a novel candidate sorting receptor purified from human brain by receptor-associated protein affinity chromatography. J Biol Chem 272 (1997) 3599-3605
21. Pettibone D.J., Hess J.F., Hey P.J., Jacobson M.A., Leviten M., Lis E.V., et al. The effects of deleting the mouse neurotensin receptor NTS1: central and peripheral responses to neurotensin. J Pharmacol Exp Ther 300 (2002) 305-313
22. Remaury A., Vita N., Gendreau S., Jung M., Arnone M., Poncelet M., et al. Targeted inactivation of the neurotensin type 1 receptor reveals its role in body temperature control and feeding behavior but not in analgesia. Brain Res 953 (2002) 63-72
23. Rezayat M., Ravandeh N., and Zarrindast M.R. Cholecystokinin and morphine-induced hypothermia. Eur Neuropsychopharmacol 9 (1999) 219-225
24. Sarhan S., Hitchcock J.M., Grauffel C.A., and Wettstein J.G. Comparative antipsychotic profiles of neurotensin and a related systemically active peptide agonist. Peptides 18 (1997) 1223-1227
25. Sarret P., Esdaile M.J., Perron A., Martinez J., Stroh T., and Beaudet A. Potent spinal analgesia elicited throught stimulation of NTS2 receptors. J Neurosci 25 (2005) 8188-8196
26. Stiller C.O., Gustafsson H., Fried K., and Brodin E. Opioid-induced release of neurotensin in the periaqueductal gray matter of freely moving rats. Brain Res 774 (1997) 149-158
27. Tanaka K., Masu M., and Nakanishi S. Structure and functional expression of the rat neurotensin receptor. Neuron 4 (1990) 847-854
28. Tyler B.M., Groshan K., Cusack B., and Richelson E. In vivo studies with low doses of levocabastine and diphenhydramine, but not pyrilamine, antagonize neurotensin-mediated antinociception. Brain Res 787 (1998) 78-84
29. Yamauchi R., Usui H., Yunden J., Takenaka Y., Tani F., and Yoshikawa M. Characterization of β-lactotensin, a bioactive peptide derived from bovine β-lactoglobulin, as a neurotensin agonist. Biosci Biotechnol Biochem 67 (2003) 940-943
30. Yamauchi R., Sonoda S., Jinsmaa Y., and Yoshikawa M. Antinociception induced by β-lactotensin, a neurotensin agonist derived from β-lactoglobulin, is mediated by NT2 and D1 receptors. Life Sci 73 (2003) 1917-1923